CLOSE

Benchmark Investments

ICICI Pru Nifty Pharma Index Fund-Reg(G)

very highequityindex funds - other
16.84 -0.25(-1.48%) NAV as on 30 Mar 2026
-3.25 % 1 M
4.79 % 1 Y
21.99 % 3 Y

Growth Chart of the Scheme vis a vis benchmark

  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y

SCHEME DETAILS

Expenses Ratio :

1.02

As on 28 Feb, 2026
Age :

3 yrs 3 m

Since 14 12 ,2022
Exit Load :

0%

AUM :

97.03 Crs

Portfolio Price To Book Value :

6.11

Investing Style :

Large Growth

Min. Investment :

SIP 1000 & Lumpsum 1000

Category :

index funds

Fund Manager :

Nishit Patel,Ashwini Shinde,Venus Ahuja

Launch Date :

14-Dec-22

Scheme Benchmark :

NA

FUND OBJECTIVE

The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2026
Others 0.65 %
Equity 99.35 %

TOP HOLDINGS

Sun Pharmaceutical Industries...21.81 %
Divi's Laboratories Ltd.9.65 %
Dr. Reddy's Laboratories Ltd.9.29 %
Cipla Ltd.8.99 %
Lupin Ltd.6.62 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs99.35
See All Sectors

5-YEARS HISTORY

Financial Year2022-20232023-20242024-20252025-2026
NAV in Rs (as on 27-Mar-2026)9.3214.5316.0717.10
Net Assets(Rs Crores) (as on 27-Mar-2026) 12.68 45.41 80.60 97.03
Scheme Returns(%)(Absolute)-6.7555.179.408.25
B'mark Returns(%)(Absolute)NANANANA
Category Rank62/8738/1207/19922/366

Quarterly Performance - Last 5 Years (Absolute Ret. In %)

Financial Year Q1 Q2 Q3 Q4
2025-20264.15-2.605.66NA
2024-20253.4518.060.25-9.66
2023-202413.7011.868.7012.70
2022-2023NANANA-4.58

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

ICICI Pru Nifty Pharma Index Fund-Reg(G)Very HighEquity16.84-0.25(-1.48%)NAV As on 30 Mar, 202614-Dec-2022Inception Date97.03AUM In Cr.4.79%1Y21.99%3YNA%5Y17.15%Since Inception
Edelweiss Nifty Midcap150 Momentum 50 Index Fund-Reg(G)Very HighEquity15.67-0.48(-3.00%)NAV As on 30 Mar, 202630-Nov-2022Inception Date1,452.18AUM In Cr.-3.01%1Y19.30%3YNA%5Y14.44%Since Inception
Tata Nifty Midcap 150 Momentum 50 Index Fund-Reg(G)Very HighEquity15.63-0.48(-3.00%)NAV As on 30 Mar, 202620-Oct-2022Inception Date1,062.97AUM In Cr.-2.95%1Y18.91%3YNA%5Y13.84%Since Inception

BENCHMARK INVESTMENTS

Benchmark Investments, 6 Sector II Shanti Niketan, Govindpura Bhopal, Bhopal-462023, India. +91-755-4938282/+91-9826310337 hello@benchmarkinvestments.in.
Downloads
Quick Links
Useful Links

Mutual fund and other investments are always subject to market risks. Please read all, Scheme Information Documents (SID), Key Information Memorandum (KIM), Addendums(if any) issued there to from time to time and any other related documents or information carefully before investing. Past performance is not indicative or assurance of future performance or returns. Please consider your specific investment requirements before choosing a fund.

For any grievances, investors can contact at: hello@benchmarkinvestments.in,  Tel: +91-755-4938282 / +91-9826310337.
©  Copyrights 2022 , Benchmark Investments | All Rights Reserved |  Designed, Developed & Content Powered by Accord Fintech Pvt Ltd